Results 201 to 210 of about 33,007,624 (364)

Analysis of Generation Z Consumer Decisions in Using QRIS as a Digital Payment System

Pasya Adinda Putri, Virgi Baker Awan Zibarani, Gisheila Hana Lysa, Marshall Ramadhan, Rizka Zakiah   +4 more
openalex   +2 more sources

Hierarchy Analysis Method as Investment Decision Support Tool [PDF]

, 2017
Nikolai Vladimirovich Kotelnikov, N.G. Urazova, Alexandra Mikhailovna Ohanova   +2 more
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Multi-criteria decision analysis of value evaluation of rare disease medical insurance drugs in China. [PDF]

BMC Public Health
Chen K, Duan Y, Cao Z, Wu Y, Wang J, Jiang B, Gu R.   +6 more
europepmc   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Machine learning-based detection of cognitive decline using SSWTRT: classification performance and decision analysis. [PDF]

Front Artif Intell
Nozaki Y, Kamohara C, Abe R, Ieda T, Nakajima M, Sakamoto M.   +5 more
europepmc   +1 more source

Analysis of financial performance of deposit banks in Turkey using multi-criteria decision-making methods

Hakan Tutar, Yusuf Bahadır KAVAS, Batuhan Medetoğlu, Judit Koltai   +3 more
openalex   +1 more source

Decision letter for "Target highlights in CASP14 : analysis of models by structure providers"

, 2021

openalex   +1 more source

Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force.

Value in Health, 2016
K. Marsh, Maarten J. IJzerman, P. Thokala, R. Baltussen, Meindert Boysen, Z. Kaló, T. Lönngren, F. Mussen, S. Peacock, John B. Watkins, N. Devlin   +10 more
semanticscholar   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source